Multiple Myeloma
Conference Coverage
ASPIRE: Carfilzomib-Len-Dex ‘a new standard of care’ for relapsed multiple myeloma
Key clinical point: Adding the proteasome inhibitor carfilzomib to lenalidomide and dexamethasone resulted in a significantly better PFS in...
News
People often dismiss cancer symptoms, survey suggests
Credit: NIH People could be putting their lives at risk by dismissing potential warning signs of cancer as less serious symptoms, according to a...
News
Study shows long-term survival improvements in blood cancers
Credit: Rhoda Baer A new study suggests that half of all people recently diagnosed with cancer in England and Wales should survive their disease...
News
Drug gets orphan designation for MM & CLL/SLL
The European Medicines Agency (EMA) has granted orphan drug designation for selinexor (KPT-330) to treat multiple myeloma (MM) and chronic...
News
NICE expands use of ESAs in cancer patients
chemotherapy Credit: Rhoda Baer The UK’s National Institute for Health and Care Excellence (NICE) has updated its guidance to expand the use of...
News
Drug dubbed ‘breakthrough’ for AL amyloidosis
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation for the oral proteasome inhibitor ixazomib (MLN9708) to...
News
FDA extends review of panobinostat for combination treatment of multiple myeloma
News
Mutations indicate predisposition to blood cancers
Credit: Graham Colm Two teams of researchers have identified somatic mutations that increase the likelihood a person will develop a hematologic...
News
Exposure to hookah smoke may raise risk of blood cancers
Credit: Steven Damron A new study indicates that individuals exposed to hookah smoke have an increase in the uptake of benzene, a substance...
News
Immunologist Herman Eisen dies at 96
Photo courtesy of MIT Herman Eisen, MD, a respected immunologist, has died at the age of 96. Over a 70-year career, Dr Eisen contributed a great...
News
Combo proves active in newly diagnosed MM
Credit: Esther Dyson Combining the proteasome inhibitor ixazomib with lenalidomide and dexamethasone shows promise for treating patients with...